Skip to content

Erector Spinae vs. PENG Block for Total Hip Arthroplasty

Erector Spinae Plane Block (ESPB) vs. PENG Block for Pain Management and Stress Response in Patients Undergoing Total Hip Arthroplasty. A Prospective, Randomized Trial.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06083428
Enrollment
90
Registered
2023-10-16
Start date
2023-10-17
Completion date
2024-06-11
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Arthropathy, Hip Osteoarthritis, Hip Pain Chronic

Brief summary

Effect of PENG block and ESPB on pain management, and NLR and PLR following knee arthroplasty

Detailed description

Hip arthroplasty is one of the most common orthopedic procedures, especially in elderly patients, due to the deformation of joints. Patients may complain of severe pain due to surgical trauma and prosthesis. Regional anesthesia methods may be performed to reduce the inflammatory response, opioid consumption, and opioid-related side effects. In recent years, the influence of regional anesthesiology on reducing the inflammatory response after surgical procedures has been emphasized. However, very few studies have evaluated the effect of various methods of anesthesia on the NLR. This is the first study to investigate the effect of regional anesthesia on the NLR and PLR in patients undergoing hip replacement surgery.

Interventions

DRUGRopivacaine 0.2% Injectable Solution Erector Spinae Plane Block

ultrasound guided ESPB - L4 level, unilateral

DRUGRopivacaine 0.2% Injectable Solution - PENG block

ultrasound guided PENG block

Only spinal anesthesia

Sponsors

Poznan University of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients with ASA classification I-III, Aged 20-90 years, Who will be scheduled for hip arthroplasty under spinal anesthesia.

Exclusion criteria

* Patients who have a history of bleeding diathesis, Take anticoagulant therapy, have a History of chronic pain before surgery, have Multiple trauma, cannot assess their pain (dementia), have been operated on under general anesthesia, have an infection in the area and do not accept the procedure

Design outcomes

Primary

MeasureTime frameDescription
Opioid consumption48 hours after surgeryTotal opiate consumption after surgery

Secondary

MeasureTime frameDescription
first need of opiate48 hours after procedureTime after surgery when the patient needs opiate for the first time
Numerical Rating Scale [range 0:10]4 hours after surgeryPostoperative pain assessment will be performed using the NRS score (0 = no pain, 10 = the most severe pain felt)
Neutrophil-to-lymphocyte ratio24 hours after surgeryNeutrophil-to-lymphocyte ratio
Platelet-to-lymphocyte ratio24 hours after surgeryPlatelet-to-lymphocyte ratio
Quadriceps muscle strength assessed using medical research council scale [range 0:5]Postoperative 24 hours periodQuadriceps muscle strength (knee extension and hip adduction) will be evaluated according to the medical research council muscle strength rating

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026